CPA
STXS icon

Capital Performance Advisors’s Stereotaxis STXS Stock Holding History

Capital Performance Advisors’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-43
Closed -$88 – 2376
2024
Q3 		$88 Buy
+43
New +$87 ﹤0.01% 2719

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Capital Performance Advisors's STXS Position: Q4 2024 in Review

Capital Performance Advisors sold out of Stereotaxis (STXS) in Q4 2024, closing a stake of 43 shares — an estimated $88 sold.

Capital Performance Advisors first reported a position in STXS in Q3 2024 and held it in 1 quarter. The position peaked at $88 in Q3 2024. 86 funds tracked by Wall St. Rank hold STXS as of Q4 2024.

  • Capital Performance Advisors reported no remaining Stereotaxis position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 43 Stereotaxis shares in Q4 2024, an estimated $88.
  • Capital Performance Advisors first reported a position in Stereotaxis in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Stereotaxis position peaked at $88 in Q3 2024.
  • 86 funds tracked by Wall St. Rank held Stereotaxis as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.